Ocular Hypertension
Showing NaN - NaN of 19
Safety Study of Bimatoprost Intracameral Implant (DURYSTA)
Recruiting
- Open-angle Glaucoma
- Ocular Hypertension
-
Culver City, California
- +24 more
Feb 21, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Brimonidine Tartrate Ophthalmic Suspension
- Brimonidine Tartrate Ophthalmic Solution
-
Chandler, Arizona
- +46 more
Jan 27, 2022
Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham: Applicator Without Needle, Active
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- Bimatoprost SR
- +3 more
-
Dothan, Alabama
- +112 more
Jul 6, 2021
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- PF-04217329 - Lowest Dose
- +8 more
-
Artesia, California
- +22 more
Apr 6, 2021
Glaucoma, Open-Angle, Ocular Hypertension Trial in Canada, United States (Xalacom, Xalatan, Timolol)
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- Xalacom
- +2 more
-
Phoenix, Arizona
- +54 more
Feb 17, 2021
Ocular Hypertension, Glaucoma Trial in United States (latanoprost 0.005%, fixed combination latanoprost-timolol, timolol 0.5%)
Completed
- Ocular Hypertension
- Glaucoma
- latanoprost 0.005%
- +2 more
-
Anaheim, California
- +52 more
Feb 17, 2021
Glaucoma, Ocular Hypertension Trial in United States (latanoprost 0.005% ophthalmic solution, Travoprost 004% sterile ophthalmic
Completed
- Glaucoma
- Ocular Hypertension
- latanoprost 0.005% ophthalmic solution
- +2 more
-
Bellflower, California
- +39 more
Feb 1, 2021
Glaucoma, Ocular Hypertension Trial in United States (RKI983A, Latanoprost)
Completed
- Glaucoma
- Ocular Hypertension
-
Artesia, California
- +28 more
Dec 11, 2020
Primary Open Angle Glaucoma, Ocular Hypertension, Pigmentary Glaucoma Trial in United States (PF-03187207 and Latanoprost
Completed
- Primary Open Angle Glaucoma
- +3 more
- PF-03187207 and Latanoprost Vehicle
- Latanoprost 0.005% and PF-03187207 Vehicle
-
Artesia, California
- +18 more
Sep 10, 2020
Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- bimatoprost 20 µg generation 2
- +6 more
-
Artesia, California
- +56 more
Mar 27, 2020
Glaucoma, Ocular Hypertension Trial in Atlanta (bimatoprost eye drops, )
Completed
- Glaucoma
- Ocular Hypertension
- bimatoprost eye drops
- placebo
-
Atlanta, Georgia(unnamed)
Apr 10, 2019
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
-
Artesia, California
- +9 more
Feb 1, 2019
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost
- +3 more
-
Artesia, California
- +9 more
Mar 22, 2018
Ocular Hypertension, Open-Angle Glaucoma, Exfoliation Syndrome Trial in United States (timolol maleate, dorzolamide/timolol
Completed
- Ocular Hypertension
- +3 more
- timolol maleate
- dorzolamide/timolol maleate fixed combination
-
Little Rock, Arkansas
- +4 more
Nov 18, 2008
Glaucoma, Ocular Hypertension Trial in Atlanta (Brimonidine ophthalmic solution 0.1%, Brimonidine ophthalmic solution 0.2%)
Completed
- Glaucoma
- Ocular Hypertension
- Brimonidine ophthalmic solution 0.1%
- Brimonidine ophthalmic solution 0.2%
-
Atlanta, Georgia(unnamed)
Apr 1, 2008
Glaucoma, Ocular Hypertension Trial in Atlanta (latanoprost 0.005% eye drops and brimonidine 0.1% eye drops, latanoprost 0.005%
Completed
- Glaucoma
- Ocular Hypertension
- latanoprost 0.005% eye drops and brimonidine 0.1% eye drops
- latanoprost 0.005% eye drops and brinzolamide 1.0% eye drops
-
Atlanta, Georgia(unnamed)
Dec 26, 2007
Open Angle Glaucoma, Ocular Hypertension, Pseudoexfoliation Syndrome Trial in United States (Travatan, Azopt, Alphagan P)
Completed
- Open Angle Glaucoma
- +2 more
- Travatan
- +2 more
-
Los Angeles, California
- +20 more
Feb 22, 2006